Edwards Lifesciences announced that the FDA has approved an aortic valve conduit for use during bio-Bentall procedures. The aortic valve conduit (Konect Resilia), which is used during surgery to replace a patient’s aortic root, aortic valve or ascending aorta, incorporates tissue with preservation technology to improve durability of the valve, according to a press release from the company.
|